COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 74: Articles 731-740  | Next

Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada
Simmons, A. E., Miranda, R. N., Li, M. W. Z., Gebretekle, G. B., Xi, M., Salvadori, M. I., Warshawsky, B., Wong, E., Ximenes, R., Andrew, M. K., Wilson, S., Tunis, M., Tuite, A. R.
10.1101/2024.12.13.24318988 — Posted: 2024-12-14
Evaluation of T Cell Immune Memory Response after Sinopharm (BBIBP-CorV), Gam-COVID-Vac (Sputnik-V), and Heterologous Sputnik-V/mRNA-1273 (Moderna) COVID-19 Vaccination Schemes against Different SARS-CoV-2 Variants.
Pereson, M. J., Badano, M. N., Sabbione, F., Keitelman, I., Aloisi, N., Fink, S., Amaya, L., Garcia, G., Martinez, A., Di Lello, F. A., Bare, P.
10.1101/2024.12.13.24318016 — Posted: 2024-12-14
Subjective experience of women with childbirth in hospitals after COVID-19 outbreak: Insights from Babies Born Better survey
Greskovicova, K., Nemcova, M., Sikova, T.
10.1101/2024.12.12.24318966 — Posted: 2024-12-14
Estimating changes in life expectancy in Hong Kong during the COVID-19 pandemic
Law, A. H. T., Presanis, A. M., Cheung, J. K., Wu, P., Schooling, M., Cowling, B. J., Wong, J. Y.
10.1101/2024.12.12.24318910 — Posted: 2024-12-13
COVID-19 Vaccine Acceptance and Hesitancy in Cameroon: A Systematic Review and Meta-analysis
Cheuyem, F. Z. L., Amani, A., Nkodo, I. C. A., Boukeng, L. B. K., Edzamba, M. F., Nouko, A., Guissana, E. O., Ngos, C. S., Achangwa, C., Mouangue, C.
10.1101/2024.12.12.24318938 — Posted: 2024-12-13
Exploring the help-seeking journeys for Long Covid from a health inequalities perspective: a qualitative study in England
Clutterbuck, D., Ramasawmy, M., Pantelic, M., Allsopp, G., Gabbay, M., Hayer, J., Heightman, M., Mu, Y., Sunkersing, D., Wootton, D., Banerjee, A., Alwan, N. A., the STIMULATE-ICP Consortium
10.1101/2024.12.12.24318614 — Posted: 2024-12-13
Histopathological Evaluation of Pulmonary Arterial Remodeling in COVID-19
Gychka, S. G., Nikolaienko, S. I., Shults, N. V., Vasylyk, V. M., Pasichnyk, B. O., Kagan, I. V., Dibrova, Y. V., Tuffaha, M., Suzuki, Y. J.
10.1101/2024.12.12.628253 — Posted: 2024-12-13
Subtle changes at the RBD/hACE2 interface during SARS-CoV2 variant evolution: a molecular dynamics study
Gheeraert, A., Leroux, V., Mias-Lucquin, D., Karami, Y., Vuillon, L., Chauvot de Bauchene, I., Devignes, M.-D., Rivalta, I., Maigret, B., Chaloin, L.
10.1101/2024.12.12.628120 — Posted: 2024-12-13
Angiotensin peptides enhance SARS-CoV-2 spike protein binding to its host cell receptors
Oliveira, K. X., Suzuki, Y. J.
10.1101/2024.12.12.628247 — Posted: 2024-12-13
SARS-CoV-2 Nsp14 binds Tollip and activates pro-inflammatory pathways while downregulating interferon alpha and interferon gamma receptors
Thakur, N., Chakraborty, P., Tufariello, J. M., Basler, C. F.
10.1101/2024.12.12.628214 — Posted: 2024-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).